Optimizing pediatric ITP therapy: a real-world study on plasma concentration-guided eltrombopag dosing
Abstract Eltrombopag (ELT) is a second-line therapy for pediatric immune thrombocytopenia (ITP), but inter-individual variability in metabolism leads to wide plasma concentration differences at the same dose, affecting efficacy and adverse drug reactions (ADRs). To validate the feasibility of indivi...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2026-03-01
|
| Col·lecció: | Annals of Hematology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s00277-026-06875-8 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|